SEC Form 4 · accession 0001140361-15-042389
Loxo Oncology, Inc. · LOXO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Avi Z. Naider
Director
Period of report
Nov 17, 2015
Accepted (ET)
Nov 19, 2015 · 7:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001581720
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 17, 2015 | P | 3,773 | $26.50 | A | 159,118 | D |
Table II — derivative securities
No Table II lines on this filing.